Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update that does not change the study details shown on the page.
    Difference
    0.1%
    Check dated 2026-08-11T18:25:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new page/version release. No visible study content changes are described in the provided data.
    Difference
    0.1%
    Check dated 2026-07-28T11:31:20.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3, signaling a new page build. This update reflects a platform or asset patch rather than changes to the study data or presentation of the trial details.
    Difference
    0.1%
    Check dated 2026-06-30T01:24:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    New navigation and guidance links were added to help users check eligibility, locate contact information, read the study record, and learn how to join the study. A formatting tweak to the Intervention/Treatment header and a revision tag update from v3.5.5 to v3.6.0 were applied.
    Difference
    0.5%
    Check dated 2026-06-15T18:47:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5. This indicates a new deployment or update to the page without changing the study information.
    Difference
    0.1%
    Check dated 2026-06-08T16:51:59.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (Revision: v3.5.4), indicating an administrative update to the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:50:28.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.